# A Clinical Study Comparing Basic Performance and Hemocompatibility of 3 Different Dialyzers in Hemodialysis Patients

> **NCT02433210** · NA · COMPLETED · sponsor: **University of Missouri-Columbia** · enrollment: 11 (actual)

## Conditions studied

- End Stage Renal Disease (ESRD)

## Interventions

- **DEVICE:** ELISIO-15H
- **DEVICE:** Revaclear
- **DEVICE:** Optiflux

## Key facts

- **NCT ID:** NCT02433210
- **Lead sponsor:** University of Missouri-Columbia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2017-11-30
- **Final completion:** 2018-08-31
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2022-08-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02433210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02433210, "A Clinical Study Comparing Basic Performance and Hemocompatibility of 3 Different Dialyzers in Hemodialysis Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02433210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
